Research ID
hum0091-v1Release info
Research title
Study of molecular-genetics, and molecular epidemiology for developing treatment of esophageal cancer (GAC series)
Research overview
- Aims
- The aim of this study is to participate in International Human Epigenome Consortium (http://ihec-epigenomes.org/), through disclosure of quality reference epigenome profiles in normal and diseased cells obtained from multiple Japanese people.
- Methods
- ChIP-Seq, RNA-seq and PBAT-seq analysis about normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method.
- Participants/materials
- Normal human foveolar epithelial cells of the stomach purified from gastrectomy specimens using crypt isolation method : 14 cells
Datasets
| Cart | Dataset ID | Type of data | Analysis method | Access criteria | Date published |
|---|---|---|---|---|---|
| JGAD000082 | NGS (PBAT-seq) |
| Controlled-access (Type I) | 2021-03-12 | |
| JGAD000243 | NGS (ChIP-seq) |
| Controlled-access (Type I) | 2021-03-12 | |
| JGAD000081 | NGS (RNA-seq) |
| Controlled-access (Type I) | 2021-03-12 |
Data provider
- Principal investigator
- Yae Kanai
- Affiliation
- Department of Pathology, Keio University School of Medicine
Research projects
| Name | URL |
|---|---|
AMED-CREST International Human Epigenome Consortium (IHEC) Team Kanai |
Grants
| Name | Title | Project number |
|---|---|---|
Core Research and Evolutional Science and Technology, Advanced Research & Development Programs for Medical Innovation, Japan Agency for Medical Research and Development (AMED-CREST) | Development of Fundamental Technologies for Diagnosis and Therapy Based upon Epigenome Analysis | N/A |
Related publications
No related publications.
Controlled access users
| Principal investigator | Affiliation | Country/Region | Research title | Period of data use | Dataset ID |
|---|---|---|---|---|---|
| Michiaki Hamada | Hamada Laboratory, Faculty of Science and Engineering, Waseda University | Japan | Construction of RNA-targeted Drug Discovery Database | 2023-01-05 – 2027-10-31 |